(2-Fluoro-3-methoxy-5-methyl-phenyl)-methanol | 307975-07-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2-Fluoro-3-methoxy-5-methyl-phenyl)-methanol
• 英文别名: (2-Fluoro-3-methoxy-5-methylphenyl)methanol
• CAS: 307975-07-1
• 化学式: C₉H₁₁FO₂
• mdl: MFCD11110179
• 分子量: 170.184
• InChiKey: RRHYOCPKVHRRLC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2-Fluoro-3-methoxy-5-methyl-phenyl)-methanol 在 四溴化碳 、 三苯基膦 作用下， 生成 1-bromomethyl-2-fluoro-3-methoxy-5-methylbenzene
  参考文献：
  名称：

  Discovery of selective metal-binding peptoids using 19F encoded combinatorial libraries

  摘要：

  A method for encoding solid-phase split/mix combinatorial libraries using the chemical shift of synthetic fluoroarenes ('F-codes') has been developed. They have wide chemical shift dispersion and are detectable at the sub-mu mol level. F-19 NMR is used for decoding. Nine fluoroarenes bearing linkers for attachment to solid-phase synthesis supports through a photocleavable group were prepared. A library of 90 N-alkylglycines bearings substituted succinamides was prepared on solid phase from nine amines, in which the amine is encoded by the fluorinated tag, and 10 anhydrides. Metal binding studies followed by decoding identified unique, specific binders of copper(II) and iron(III) with mu M K(D)s. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00416-9
• 作为产物：
  描述：

  2-fluoro-3-methoxy-5-methylbenzoic acid 在 lithium aluminium tetrahydride 作用下， 生成 (2-Fluoro-3-methoxy-5-methyl-phenyl)-methanol
  参考文献：
  名称：

  Discovery of selective metal-binding peptoids using 19F encoded combinatorial libraries

  摘要：

  A method for encoding solid-phase split/mix combinatorial libraries using the chemical shift of synthetic fluoroarenes ('F-codes') has been developed. They have wide chemical shift dispersion and are detectable at the sub-mu mol level. F-19 NMR is used for decoding. Nine fluoroarenes bearing linkers for attachment to solid-phase synthesis supports through a photocleavable group were prepared. A library of 90 N-alkylglycines bearings substituted succinamides was prepared on solid phase from nine amines, in which the amine is encoded by the fluorinated tag, and 10 anhydrides. Metal binding studies followed by decoding identified unique, specific binders of copper(II) and iron(III) with mu M K(D)s. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00416-9

文献信息

• NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND
  申请人：KOTOBUKI PHARMACEUTICAL CO., LTD.

  公开号：US20140142084A1

  公开（公告）日：2014-05-22

  Provided is a compound useful as a prophylactic and/or therapeutic agent for bladder cancer. As a result of studies on compounds having FGFR inhibitory action, the present inventors have found that the nitrogen-containing aromatic heterocyclic compounds of the present invention have inhibitory action on FGFR1, FGFR2, and/or FGFR3, particularly, mutant FGFR3, and thus, the present invention has been accomplished. The nitrogen-containing aromatic heterocyclic compound of the present invention can be used as a therapeutic agent for various cancers related to FGFR1, FGFR2, and/or FGFR3, such as lung cancer and hormone therapy-resistant breast cancer, stomach cancer, triple negative breast cancer, endometrial cancer, bladder cancer, and glioblastoma, particularly as a prophylactic and/or therapeutic agent for mutant FGFR3-positive bladder cancer.

  提供了一种化合物，可作为膀胱癌的预防和/或治疗药物。通过对具有FGFR抑制作用的化合物进行研究，本发明人发现本发明的含氮芳香杂环化合物对FGFR1、FGFR2和/或FGFR3，特别是突变FGFR3具有抑制作用，因此完成了本发明。本发明的含氮芳香杂环化合物可用作与FGFR1、FGFR2和/或FGFR3相关的各种癌症的治疗药物，如肺癌和激素治疗耐药性乳腺癌、胃癌、三阴性乳腺癌、子宫内膜癌、膀胱癌和胶质母细胞瘤，特别是作为突变FGFR3阳性膀胱癌的预防和/或治疗药物。
• HETEROARYL COMPOUNDS AND USES THEREOF
  申请人：CELGENE AVILOMICS RESEARCH, INC.

  公开号：US20160046634A1

  公开（公告）日：2016-02-18

  The present invention relates to compounds useful as inhibitors of protein kinases, containing a cysteine residue in the ATP binding site. The invention further provides for pharmaceutically acceptable compositions comprising therapeutically effective amounts of one or more of the protein kinase inhibitor compounds and methods of using said compositions in the treatment of cancers and carcinomas.
• US9464077B2
  申请人：——

  公开号：US9464077B2

  公开（公告）日：2016-10-11
• US9663524B2
  申请人：——

  公开号：US9663524B2

  公开（公告）日：2017-05-30
• Discovery of selective metal-binding peptoids using 19F encoded combinatorial libraries
  作者：Michael C Pirrung、Kaapjoo Park

  DOI：10.1016/s0960-894x(00)00416-9

  日期：2000.9

  A method for encoding solid-phase split/mix combinatorial libraries using the chemical shift of synthetic fluoroarenes ('F-codes') has been developed. They have wide chemical shift dispersion and are detectable at the sub-mu mol level. F-19 NMR is used for decoding. Nine fluoroarenes bearing linkers for attachment to solid-phase synthesis supports through a photocleavable group were prepared. A library of 90 N-alkylglycines bearings substituted succinamides was prepared on solid phase from nine amines, in which the amine is encoded by the fluorinated tag, and 10 anhydrides. Metal binding studies followed by decoding identified unique, specific binders of copper(II) and iron(III) with mu M K(D)s. (C) 2000 Elsevier Science Ltd. All rights reserved.